Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Moodys
Harvard Business School
Chinese Patent Office
Accenture
Colorcon
QuintilesIMS
US Department of Justice

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021011

« Back to Dashboard

NDA 021011 describes ROXICODONE, which is a drug marketed by Roxane and Specgx Llc and is included in two NDAs. It is available from one supplier. Additional details are available on the ROXICODONE profile page.

The generic ingredient in ROXICODONE is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.
Summary for 021011
Tradename:ROXICODONE
Applicant:Specgx Llc
Ingredient:oxycodone hydrochloride
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details
Pharmacology for NDA: 021011
Mechanism of ActionFull Opioid Agonists
Suppliers and Packaging for NDA: 021011
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ROXICODONE oxycodone hydrochloride TABLET;ORAL 021011 NDA SpecGx LLC 23635-580 N 23635-580-10
ROXICODONE oxycodone hydrochloride TABLET;ORAL 021011 NDA SpecGx LLC 23635-580 N 23635-580-25

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength15MG
Approval Date:Aug 31, 2000TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength30MG
Approval Date:Aug 31, 2000TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:May 15, 2009TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fuji
McKesson
Accenture
Healthtrust
US Army
Mallinckrodt
Julphar
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.